KMDA Kamada Ltd.

Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops & produces specialty plasma-derived protein therapeutics. Its flagship product include Glassia.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol IT:KMDA.

$6.18
As of 04/14/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/31/2013
Outstanding shares:  44,742,963
Average volume:  78,098
Market cap:   $269,800,067
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M6240T109
ISIN:        IL0010941198
Sedol:      B2Q9833
Valuation   (See tab for details)
PE ratio:   15.74
PB ratio:   1.51
PS ratio:   2.02
Return on equity:   9.59%
Net income %:   12.86%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy